BMYTICKER
Bristol Myers Squibb Co.
Congress has disclosed 42 buys and 44 sells of BMY (Bristol Myers Squibb Co.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
42
Buy
44
Sell
-2
Net
28
Active politicians
Round-trip watch Still on the books
Members who disclosed buying BMY and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rohit Khanna | 2025-11-03 | $44.06 | $62.48 | +41.8% | in profit |
| Valerie Hoyle | 2024-10-29 | $47.88 | $62.48 | +30.5% | in profit |
| Gilbert Cisneros | 2025-12-19 | $51.88 | $62.48 | +20.4% | in profit |
| Alan Armstrong | 2026-03-27 | $56.71 | $62.48 | +10.2% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
13.82
▼ cheaper than
Health (median 29.7)
how it's calculated
P/E = price ÷ earnings per share
$62.48 ÷ $4.52 = 13.82
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
5.46
▲ pricier than
Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$62.48 ÷ $11.45 = 5.46
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
87 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Alan Armstrong | Senate | BUY ◆ insider divergence | Self | 2026-03-27 | 116 days | +6.3% | $1K–$15K | 99.1 | ↗ eFD |
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2025-12-19 | 21 days | +4.3% | $1K–$15K 0.1% of NW |
0.7 | ↗ filing |
| Julie Johnson | House | SELL | Joint · Chase Brokerage Account (3935) | 2025-12-18 | 18 days | +0.7% | $1K–$15K <0.1% of NW |
5.0 | ↗ filing |
| Julie Johnson | House | SELL | Joint · Chase Brokerage Account (3935) | 2025-11-13 | 22 days | +7.2% | $1K–$15K <0.1% of NW |
7.6 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2025-11-12 | 30 days | +6.8% | $1K–$15K 0.1% of NW |
9.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2025-11-03 | 31 days | +12.9% | $1K–$15K | 13.0 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence | Joint · Chase Brokerage Account (3935) | 2025-08-14 | 19 days | -0.8% | $1K–$15K <0.1% of NW |
13.1 | ↗ filing |
| Virginia Foxx | House | SELL ◆ insider divergence · moderate | Self | 2025-06-24 | 7 days | +1.0% | $1K–$15K 0.2% of NW |
97.4 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | -4.9% | $15K–$50K <0.1% of NW |
84.7 | ↗ filing |
| Julia Letlow | House | SELL ◆ insider divergence · moderate | Self · Merrill Lynch Investment Account #025 | 2025-04-28 | 105 days | -4.0% | $1K–$15K 1.0% of NW |
54.5 | ↗ filing |
| Thomas Tuberville | Senate | OTHER | Self | 2025-04-15 | 477 days | +35.1% | $1K–$15K | 98.8 | ↗ eFD |
| Julie Johnson | House | SELL ◆ insider divergence · strong | Joint · Merrill Lynch Tax Efficient Core | 2025-04-01 | 35 days | -19.3% | $1K–$15K <0.1% of NW |
50.7 | ↗ filing |
| Greg Landsman | House | SELL ◆ insider divergence · strong | Joint · Rockefeller Capital Management (2) | 2025-03-27 | 8 days | -5.1% | $1K–$15K 0.6% of NW |
98.2 | ↗ filing |
| Julie Johnson | House | BUY ◆ insider convergence · strong | Joint · Merrill Lynch Tax Efficient Core | 2025-01-15 | 23 days | +1.7% | $1K–$15K <0.1% of NW |
62.6 | ↗ filing |
| Valerie Hoyle | House | BUY ◆ insider convergence · moderate | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | -6.2% | $1K–$15K 0.8% of NW |
69.5 | ↗ filing |
| Julia Letlow | House | BUY ◆ insider convergence · moderate | Self · Merrill Lynch Investment Account #025 | 2024-10-23 | 292 days | -10.4% | $1K–$15K 1.0% of NW |
69.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2024-07-02 | 34 days | — | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2024-04-26 | 5 days | — | $1K–$15K | 2.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2024-03-25 | 9 days | — | $15K–$50K | 18.9 | ↗ filing |
| Rohit Khanna | House | SELL OCR | Child | 2024-02-13 | 21 days | — | $1K–$15K | 14.1 | ↗ filing |
| John James | House | SELL ◆ insider divergence · strong | Self · John A. James Children’s Trust | 2024-01-18 | 222 days | — | $1K–$15K <0.1% of NW |
93.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2024-01-10 | 23 days | — | $15K–$50K | 20.1 | ↗ filing |
| Rick Larsen | House | SELL ◆ insider divergence · strong | Self · Richard R Larsen IRA > Rick Larsen IRA Ameriprise SPS Managed Account | 2024-01-09 | 3 days | — | $1K–$15K 0.7% of NW |
48.8 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence · strong | Child | 2023-12-05 | 30 days | — | $1K–$15K | 8.6 | ↗ filing |
| John James | House | BUY ◆ insider convergence · strong | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
99.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2023-11-03 | 32 days | — | $1K–$15K | 19.6 | ↗ filing |
| Greg Stanton | House | SELL ◆ insider divergence · strong | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
40.4 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider convergence · moderate | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
86.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-08-29 | 7 days | — | $15K–$50K | 49.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-04-25 | 8 days | — | $1K–$15K | 22.3 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider convergence · moderate | Self · Daniel Goldman 1997 Trust > DSG Investment Holdings LLC > TACS | 2023-03-07 | 27 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider convergence · moderate | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-03-06 | 28 days | — | $100K–$250K 0.1% of NW |
96.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-02-14 | 15 days | — | $1K–$15K | 40.4 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2023-01-11 | 22 days | — | $15K–$50K | 90.9 | ↗ filing |
| Kathy Manning | House | BUY | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #3 | 2022-07-15 | 18 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| John Rutherford | House | SELL | Self · Westend ETF | 2022-03-16 | 0 days | — | $1K–$15K 0.8% of NW |
15.7 | ↗ filing |
| Carol Devine Miller | House | SELL | Spouse | 2021-11-10 | 21 days | — | $15K–$50K 0.1% of NW |
99.8 | ↗ filing |
| Kim Schrier | House | SELL | Joint | 2021-10-28 | 1 days | — | $1K–$15K <0.1% of NW |
99.4 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2021-09-23 | 15 days | — | $1K–$15K | 10.6 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2021-09-22 | 16 days | — | $1K–$15K | 15.7 | ↗ filing |
| Thomas Suozzi | House | SELL | Self | 2021-06-07 | 23 days | — | $1K–$15K 0.1% of NW |
6.8 | ↗ filing |
| Thomas Suozzi | House | SELL | Self · Merrill Lynch- Advisor Discretion Account | 2021-06-07 | 23 days | — | $1K–$15K 0.1% of NW |
6.8 | ↗ filing |
| Thomas Suozzi | House | SELL | Self | 2021-06-04 | 26 days | — | $1K–$15K 0.1% of NW |
8.6 | ↗ filing |
| Rick Larsen | House | BUY | Self · Richard R Larsen IRA > Ameriprise SPS Managed Account | 2020-11-25 | 904 days | — | $1K–$15K 0.7% of NW |
75.9 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2020-10-22 | 36 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Thomas Suozzi | House | SELL | Self · Merrill Lynch- Advisor Discretion Account | 2020-07-10 | 21 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| John Rutherford | House | BUY | Self | 2020-06-21 | 0 days | — | $1K–$15K 0.8% of NW |
22.3 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2020-04-03 | 48 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2020-03-18 | 28 days | — | $1K–$15K 0.1% of NW |
18.1 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2020-02-20 | 12 days | — | $1K–$15K 0.1% of NW |
26.5 | ↗ filing |
| Mikie Sherrill | House | BUY | Self | 2020-01-21 | 17 days | — | $1K–$15K 0.1% of NW |
50.5 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-01-14 | 28 days | — | $1K–$15K 0.1% of NW |
31.0 | ↗ filing |
| Thomas Suozzi | House | BUY | Self | 2020-01-09 | 22 days | — | $50K–$100K 0.7% of NW |
60.5 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2019-12-18 | 16 days | — | $1K–$15K 0.1% of NW |
59.5 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2019-11-26 | 14 days | — | $1K–$15K 0.1% of NW |
33.6 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2019-11-22 | 14 days | — | $1K–$15K <0.1% of NW |
50.5 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2019-11-21 | 0 days | — | $1K–$15K <0.1% of NW |
93.1 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2019-11-21 | 15 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2019-08-14 | 27 days | — | $1K–$15K 0.1% of NW |
31.8 | ↗ filing |
| Mikie Sherrill | House | BUY | Self | 2019-07-25 | 32 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| John Rutherford | House | SELL | Self | 2019-07-10 | 2 days | — | $1K–$15K 0.8% of NW |
40.4 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2019-05-09 | 29 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2019-04-23 | 15 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Thomas Suozzi | House | SELL | Self · Merrill Lynch- Advisor Discretion Account | 2019-04-08 | 22 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2018-11-26 | 11 days | — | $1K–$15K | 22.3 | ↗ filing |
| Thomas Suozzi | House | BUY | Self | 2018-10-01 | 29 days | — | $15K–$50K 0.3% of NW |
56.6 | ↗ filing |
| Carlos Curbelo | House | SELL | Spouse | 2018-06-08 | 22 days | — | $1K–$15K | 40.4 | ↗ filing |
| Thomas Suozzi | House | BUY | Self · Merrill Lynch- Advisor Discretion Account | 2018-04-17 | 13 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| Carlos Curbelo | House | BUY | Spouse | 2018-04-06 | 24 days | — | $1K–$15K | 86.8 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2018-03-20 | 14 days | — | $1K–$15K | 4.5 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2017-12-21 | 16 days | — | $1K–$15K | 75.9 | ↗ filing |
| John Yarmuth | House | BUY | Self | 2017-12-21 | 16 days | — | $1K–$15K | 75.9 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2017-09-25 | 4 days | — | $15K–$50K | 56.6 | ↗ filing |
| John Rutherford | House | BUY | Self | 2017-08-16 | 15 days | — | $1K–$15K 0.8% of NW |
86.8 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2017-07-27 | 7 days | — | $15K–$50K | 94.9 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2017-04-27 | 8 days | — | $1K–$15K | 5.5 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2017-03-28 | 6 days | — | $1K–$15K | 6.8 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2016-08-17 | 5 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2016-02-11 | 28 days | — | $1K–$15K | 18.1 | ↗ filing |
| Robert Wittman | House | SELL | Self | 2016-01-12 | 3 days | — | $1K–$15K 0.2% of NW |
52.4 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2015-11-16 | 15 days | — | $1K–$15K | 10.6 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2015-10-21 | 14 days | — | $1K–$15K | 15.7 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2015-09-17 | 14 days | — | $1K–$15K | 31.8 | ↗ filing |
| Robert Wittman | House | BUY | Self | 2015-09-15 | 3 days | — | $1K–$15K 0.2% of NW |
86.8 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2014-10-31 | 31 days | — | $1K–$15K | 40.4 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2014-07-31 | 33 days | — | $1K–$15K | 75.9 | ↗ filing |
| Bill Flores | House | SELL | Self | 2014-02-05 | 26 days | — | $50K–$100K | 94.3 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in BMY — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
11
Congress trades with insider convergence
13
…with insider divergence
20
Insider open-market trades
Of the congressional trades in BMY, 11 coincided with corporate insiders moving the same way within 60 days, and 13 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-09-09 | Massacesi Cristian | C-suite | SELL | $403K | ↗ EDGAR |
| 2026-08-25 | Holzer Phil M | Other | SELL | $34K | ↗ EDGAR |
| 2026-04-01 | Elkins David V | C-suite | SELL 10b5-1 | $1.6M | ↗ EDGAR |
| 2026-04-01 | Elkins David V | C-suite | SELL 10b5-1 | $278K | ↗ EDGAR |
| 2025-09-02 | Elkins David V | C-suite | SELL 10b5-1 | $2.7M | ↗ EDGAR |
| 2025-08-02 | Short Bartie Wendy | Other | SELL | $17K | ↗ EDGAR |
| 2025-05-09 | Hickey Benjamin | C-suite | SELL | $4K | ↗ EDGAR |
| 2025-04-25 | Hirawat Samit | C-suite | BUY | $202K | ↗ EDGAR |
| 2025-02-20 | BOERNER CHRISTOPHER S. | C-suite | BUY | $110K | ↗ EDGAR |
| 2025-02-14 | Hirawat Samit | C-suite | BUY | $100K | ↗ EDGAR |
| 2024-11-04 | Holzer Phil M | Other | SELL | $39K | ↗ EDGAR |
| 2024-11-01 | Hirawat Samit | C-suite | BUY | $100K | ↗ EDGAR |
| 2023-12-05 | BOERNER CHRISTOPHER S. | C-suite | BUY | $100K | ↗ EDGAR |
| 2023-11-28 | BOERNER CHRISTOPHER S. | C-suite | BUY | $150K | ↗ EDGAR |
| 2023-11-20 | Samuels Theodore R. II | Director | BUY | $423K | ↗ EDGAR |
| 2023-08-24 | Powell Ann | C-suite | SELL | $1.1M | ↗ EDGAR |
| 2023-08-03 | Plenge Robert M | C-suite | SELL | $45K | ↗ EDGAR |
| 2023-05-03 | VESSEY RUPERT | C-suite | SELL | $3.4M | ↗ EDGAR |
| 2023-02-06 | Powell Ann | C-suite | SELL | $835K | ↗ EDGAR |
| 2023-02-06 | Caforio Giovanni | C-suite | SELL | $17.9M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-09-09 | Massacesi Cristian C-suite | SELL | $403K |
| ◆ insider | 2026-08-25 | Holzer Phil M Other | SELL | $34K |
| ◆ insider | 2026-04-01 | Elkins David V C-suite 10b5-1 | SELL | $1.6M |
| ◆ insider | 2026-04-01 | Elkins David V C-suite 10b5-1 | SELL | $278K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| Congress | 2025-12-19 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2025-12-18 | Julie Johnson | SELL | $1K–$15K |
| Congress | 2025-11-13 | Julie Johnson | SELL | $1K–$15K |
| Congress | 2025-11-12 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2025-11-03 | Rohit Khanna | BUY | $1K–$15K |
| ◆ insider | 2025-09-02 | Elkins David V C-suite 10b5-1 | SELL | $2.7M |
| Congress | 2025-08-14 | Julie Johnson | SELL | $1K–$15K |
| ◆ insider | 2025-08-02 | Short Bartie Wendy Other | SELL | $17K |
| Congress | 2025-06-24 | Virginia Foxx | SELL | $1K–$15K |
| Congress | 2025-05-12 | Jefferson Shreve | SELL | $15K–$50K |
| ◆ insider | 2025-05-09 | Hickey Benjamin C-suite | SELL | $4K |
| Congress | 2025-04-28 | Julia Letlow | SELL | $1K–$15K |
| ◆ insider | 2025-04-25 | Hirawat Samit C-suite | BUY | $202K |
| Congress | 2025-04-15 | Thomas Tuberville | OTHER | $1K–$15K |
| Congress | 2025-04-01 | Julie Johnson | SELL | $1K–$15K |
| Congress | 2025-03-27 | Greg Landsman | SELL | $1K–$15K |
| ◆ insider | 2025-02-20 | BOERNER CHRISTOPHER S. C-suite | BUY | $110K |
| ◆ insider | 2025-02-14 | Hirawat Samit C-suite | BUY | $100K |
| Congress | 2025-01-15 | Julie Johnson | BUY | $1K–$15K |
FAQ Common questions
How much has Congress traded BMY?
42 disclosed buys and 44 sells of BMY (Bristol Myers Squibb Co.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade BMY?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.